Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study of ACVBP Versus ACVBP Plus Rituximab in Previously Untreated Patients Aged From 18 to 65 Years With Low-risk Localized Diffuse Large B-cell Lymphoma (Age-adjusted IPI = 0)

NCT00140660 is registered in ClinicalTrials.gov with Lymphoma Study Association as lead sponsor.

NCT NCT00140660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00140660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study of ACVBP Versus ACVBP Plus Rituximab in Previously Untreated Patients Aged From 18 to 65 Years With Low-risk Localized Diffuse Large B-cell Lymphoma (Age-adjusted IPI = 0)
Lead sponsor
Lymphoma Study Association
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2003
Completion date
April 30, 2012
Enrollment
223 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large cell lymphoma